No Data
No Data
Maxim Group Maintains HeartSciences(HSCS.US) With Buy Rating, Maintains Target Price $12
Express News | Ascendiant Capital Maintains Buy on HeartSciences, Lowers Price Target to $14
Healthcare Up as Traders Rotate to Less Inflation-Sensitive Sectors -- Health Care Roundup
HEART TEST LABORATORIES Earnings Results: $HSCS Reports Quarterly Earnings
Heart Test Laboratories Reports Q3 Results
Express News | HeartSciences Cash And Cash Equivalents Were ~$2.6M As Of Jan. 31